EAN Congress news

The EAN is now inviting applications from national neurological societies to co-host the EAN Congress 2029 in Vienna

"The EAN Congress 2026 in Geneva showed me what a vibrant, supportive community neurology truly has," says Anastasiia Yevtushenko. "To every medical student thinking about getting involved: please go for it."

Congratulations to the winners of the Best Poster Award for the EAN Congress 2026. Check out the winning posters and all other nominated presentations here.

The EAN Resident and Research Fellow Section held the third edition of the NeuroART Competition, concluding with an exhibition of artistic talent from the neurology community at the EAN Congress 2026 in Geneva.

Look back on some of the highlights of the EAN Congress 2026, with articles, facts, figures, photos and videos from Europe’s top neurology meeting in our Congress Review e-Book.

New EAN President, Prof. Kailash Bhatia, discusses his priorities for the EAN, the role of AI in neurology, and more, in this EAN TV interview from the EAN Congress 2026

One day ahead of the EAN Congress 2026 in Geneva, neurologists and researchers from across Europe took part in the annual EAN Guidelines Workshop

We congratulate the winners of the EAN Tournament at the 12th Congress of the European Academy of Neurology in Geneva!

EAN Communications Committee member Agne Straukiene talks to Prof. Riccardo Soffietti, who delivered the Camillo Golgi Lecture at the 12th Congress of the European Academy of Neurology

eanNews Editor Benedetta Bodini talks to Prof. Daniela Berg, who delivered the Moritz Romberg Lecture at the EAN Congress 2026

Thanks to this year's group of authors who gave their time, attention, and expertise to report on some of the most relevant sessions of this year’s congress.

This EAN TV Session, organised by the Resident & Research Fellow Section, explored how AI is transforming neurology

This thought-provoking EAN TV session brought together leading African neurology experts, exploring the continent’s evolving neurological health challenges.

A full audience for this session reflected the growing interest in CIDP, autoimmune nodopathies and complement-targeted therapies.

Can someone have Alzheimer's disease before they develop symptoms? This fascinating workshop explored why the answer depends on how we define the disease—and why that debate matters more than ever in the era of disease-modifying therapies.